CareView Communications, Inc. (CRVW)
OTCMKTS · Delayed Price · Currency is USD
0.0200
-0.0100 (-33.33%)
Dec 15, 2025, 9:30 AM EST
CareView Communications Revenue
CareView Communications had revenue of $2.06M in the quarter ending September 30, 2025, with 6.84% growth. This brings the company's revenue in the last twelve months to $8.82M, up 12.05% year-over-year. In the year 2024, CareView Communications had annual revenue of $8.25M, down -14.80%.
Revenue (ttm)
8.82M
Revenue Growth
+12.05%
P/S Ratio
1.65
Revenue / Employee
142.34K
Employees
62
Market Cap
14.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.25M | -1.43M | -14.80% |
| Dec 31, 2023 | 9.68M | 1.78M | 22.57% |
| Dec 31, 2022 | 7.90M | 99.12K | 1.27% |
| Dec 31, 2021 | 7.80M | 1.31M | 20.25% |
| Dec 31, 2020 | 6.49M | 194.19K | 3.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| Northwest Biotherapeutics | 937.00K |
CareView Communications News
- 14 days ago - CareView Communications Announces New Partnership with Springfield Memorial Hospital to Advance Excellence in Patient Care - Business Wire
- 4 weeks ago - CoreWeave Shares Sink Despite Revenue Surge. Is It Time to Buy the Dip? - The Motley Fool
- 6 weeks ago - CareView Communications Supports Award-Winning Deployment of Virtual Patient Monitoring at the VA - Business Wire
- 2 months ago - Should You Buy CoreWeave Stock After the $14 Billion Meta Deal? - The Motley Fool
- 2 months ago - 2 Popular Artificial Intelligence (AI) Stocks to Sell Before They Each Drop Up to 75%, According to Certain Wall Street Analysts - The Motley Fool
- 3 months ago - Better AI Stock: Navitas Semiconductor vs. CoreWeave - The Motley Fool
- 4 months ago - Is CoreWeave a Buy, Sell, or Hold Before Aug. 13? - The Motley Fool
- 5 months ago - CareView Communications expands partnership with Northeast Georgia Medical Center - Braselton - Seeking Alpha